Global X Genomics & Biotechnology ETF is a ETF series of GLOBAL X FUNDS (series S000062676). Net assets $55.8M as of 2026-05-31. Index fund.
Showing 15 of 51 holdings by value.
| Holding | Ticker | Value | % of fund |
|---|---|---|---|
| GUARDANT HEALTH, INC. | — | $3.1M | 559.26% |
| ILLUMINA, INC. | — | $2.7M | 482.30% |
| NATERA, INC. | — | $2.3M | 415.18% |
| BIOMARIN PHARMACEUTICAL INC. | — | $2.3M | 408.61% |
| ARROWHEAD PHARMACEUTICALS, INC. | — | $2.3M | 407.07% |
| Legend Biotech Corp | — | $2.3M | 404.54% |
| Praxis Precision Medicines Inc | — | $2.2M | 400.71% |
| Twist Bioscience Corp | — | $2.2M | 396.57% |
| VERTEX PHARMACEUTICALS INCORPORATED | — | $2.2M | 394.91% |
| CRISPR Therapeutics AG | — | $2.1M | 384.57% |
| Veracyte Inc | — | $2.0M | 363.86% |
| Qiagen N.V. | — | $2.0M | 353.55% |
| BioNTech SE | — | $1.9M | 341.22% |
| BIO-TECHNE CORPORATION | — | $1.9M | 340.72% |
| MODERNA, INC. | — | $1.8M | 327.80% |
| Report date | Net assets |
|---|---|
| 2026-05-31 | $55.8M |
| 2026-02-28 | $52.4M |
| 2025-11-30 | $54.5M |
| 2025-08-31 | $46.1M |
| 2025-05-31 | $41.0M |
| 2025-02-28 | $61.8M |
| 2024-11-30 | $79.2M |
| 2024-08-31 | $84.8M |